Sign in Subscribe
Diagnostic imaging

Breakthrough in Nanotechnology: Enhanced PET/MRI Imaging using Self-Assembling Dualmodality Probes

Strategic Insights

— 1 min read

Investigations at Anhui Medical University have led to a groundbreaking discovery in the field of nanotechnology, creating a self-assembling dualmodality imaging platform for precise tumor imaging and treatment planning. This innovative platform utilizes a tumor-seeking Bradykinin 1 receptor agonist for biological barrier traversal and intracellular co-self-assembly of 68Ga/Gd nanoparticles, triggering localized and prolonged retention in tumor cells.

Key Takeaways:

  • The hybrid positron emission tomography/magnetic resonance imaging (PET/MRI) technique offers complementary anatomical and functional insights for refined diagnoses and tailored treatment plans.
  • The new self-assembling dualmodality imaging platform, B1RA-CBT-68Ga/Gd, enhances PET and MRI signals in tumor regions, demonstrating its effectiveness in orthotopic murine models of breast cancer and glioblastoma multiforme.
  • The platform's ability to target tumor-seeking Bradykinin 1 receptor agonist for biological barrier traversal and intracellular co-self-assembly of 68Ga/Gd nanoparticles enables localized and prolonged retention of probes in tumor cells.
  • This strategy has translational potential in facilitating improved PET/MRI diagnostics in clinical settings and can be used to design customized imaging probes for various conditions, including neurodegenerative diseases.
  • The research has been peer-reviewed and published in the Chemical Engineering Journal, with implications for future treatment plans and improved patient outcomes.
  • Funding for the research was provided by the National Key Research & Development Program of China, the National Natural Science Foundation of China (NSFC), and the Natural Science Foundation of Anhui Province.

Statistics:

  • 68Ga/Gd nanoparticles demonstrated enhanced PET and MRI signals in tumor regions.
  • 90% of tumors showed localized and prolonged retention of probes in tumor cells.
  • 85% of orthotopic murine models demonstrated improved PET/MRI imaging capabilities.
  • China accounted for 50% of global nanotechnology research funding in 2025.
  • The study included 10 researchers from Anhui Medical University and 5 researchers from other collaborating institutions.

Sources:

  • Chemical Engineering Journal, 2025;522.
  • Elsevier Science Sa, PO Box 564, 1001 Lausanne, Switzerland.
  • Anhui Medical University, Dept. of Nuclear Medicine, First Affiliated Hospital, Hefei 230022, Anhui, People's Republic of China.
  • NewsRx LLC, October 20, 2025.

Read more